The National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Neurological Disorders and Stroke (NINDS) are offering grants to participate in the HLA Region Genomics in Immune-Mediated Diseases Consortium. This grant is for defining the association between variations in human leukocyte antigen (HLA) and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and various immune-mediated conditions. These conditions include autoimmune diseases, primary immunodeficiencies, graft-versus-host disease (GVHD), and graft rejection in transplantation. The initiative supports both single (U01) and multi-project (U19) cooperative agreements. Approximately $3.525 million was anticipated to fund four to five new or renewal awards in FY 2010. The goal is to advance understanding of genetic factors in these complex diseases.
Opportunity ID: 48843
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-AI-09-030 |
Funding Opportunity Title: | HLA Region Genomics in Immune-Mediated Diseases (U01, U19) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jul 31, 2009 |
Last Updated Date: | – |
Original Closing Date for Applications: | Nov 19, 2009 |
Current Closing Date for Applications: | Nov 19, 2009 |
Archive Date: | Dec 20, 2009 |
Estimated Total Program Funding: | $3,525,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Independent school districts Special district governments State governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses City or township governments County governments Native American tribal governments (Federally recognized) Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Purpose. The National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Neurological Disorders and Stroke (NINDS) invite new and renewal applications from institutions to participate in the HLA Region Genomics in Immune-Mediated Diseases Consortium (HLAGC), a cooperative research group whose goals are to define the association between variations in the human leukocyte antigen (HLA) and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, including autoimmune diseases, primary immunodeficiencies, graft-versus-host disease (GVHD), and graft rejection in organ, tissue, and cell transplantation. Mechanism of Support. This FOA will utilize the single project U01 and multi-project U19 cooperative agreement grant mechanisms. Funds Available and Anticipated Number of Awards. The NIAID and NINDS anticipate that approximately $3.525 million in total costs will be available in FY 2010 to fund four to five new or renewal U01 and/or U19 awards in response to this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-09-030.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
There are no packages on this grant.